Palo Alto, California Thursday, February 13, 2025, 12:00 Hrs [IST] ...

Bayer has filed its mineralocorticoid receptor antagonist (MRA) finerenone as a treatment for a common form of heart failure ...

Bayer UK launches new CanesMeno Educational Hub and product range to transform menopause support: Leverkusen Friday, January ...

U.K.-based ad agency DAIVID said Pfizer had a strong, positive message with its ad and scored high with intense positive emotions. The commercial was also a top performer with spikes in positive ...

The optimism is rooted in new launches, Stefan Oelrich, head of Bayer’s pharma division ... we will address right where the sweet spot for us is,” Oelrich said. JPM25: After BridgeBio touts ...

The top opportunities in the genomic data analysis and interpretation market segmented by end-user will arise in the pharmaceutical and biotechnology companies segment, which will gain $756.71 million ...

For the quarter ended December 31, 2024, the fund returned -8.48% compared to the MSCI World ex USA ... Pharmaceuticals, and Consumer Health segments. The one-month return of Bayer ...

Bayer Consumer Health has launched a digital educational resource to support perimenopausal or menopausal patients in the UK. The free-to-access CanesMeno Hub has been designed to educate and empower ...

ZURICH (Reuters) - Bayer will focus on paying down debt and not make any major acquisitions in the next two or three years, the head of the German company's pharmaceuticals division said in an ...

4:45 p.m. ET As Bayer braces for the loss of Xarelto's exclusivity, the company is turning to new launches to weather the turbulence, Stefan Oelrich, head of Bayer’s pharma division, said Tuesday.